Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Arthritis Research & Therapy
Erschienen in: Arthritis Research & Therapy 2/2007

01.04.2007 | Review

Bone morphogenetic proteins in destructive and remodeling arthritis

verfasst von: Rik JU Lories, Frank P Luyten

Erschienen in: Arthritis Research & Therapy | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Joint destruction and tissue responses determine the outcome of chronic arthritis. Joint inflammation and damage are often the dominant clinical presentation. However, in some arthritic diseases, in particular the spondyloarthritides, joint remodeling is a prominent feature, with new cartilage and bone formation leading to ankylosis and contributing to loss of function. A role for bone morphogenetic proteins in joint remodeling has been demonstrated in the formation of both enthesophytes and osteophytes. Data from genetic models support a role for bone morphogenetic protein signaling in cartilage homeostasis. Finally, this signaling pathway is likely to play a steering role in the synovium.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
McInnes IB, Liew FY: Cytokine networks – towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2005, 1: 31-39. 10.1038/ncprheum0020.CrossRefPubMed
2.
Sato K, Takayanagi H: Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006, 18: 419-426. 10.1097/01.bor.0000231912.24740.a5.CrossRefPubMed
3.
Karouzakis E, Neidhart M, Gay RE, Gay S: Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett. 2006, 106: 8-13. 10.1016/j.imlet.2006.04.011.CrossRefPubMed
4.
Luyten FP, Lories RJ, Verschueren P, De Vlam K, Westhovens R: Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol. 2006, 20: 829-848. 10.1016/j.berh.2006.06.009.CrossRefPubMed
5.
Buckwalter JA: Articular cartilage injuries. Clin Orthop. 2002, 402: 21-37. 10.1097/00003086-200209000-00004.CrossRefPubMed
6.
Rau R: Is remission in rheumatoid arthritis associated with radiographic healing?. Clin Exp Rheumatol. 2006, 24: S041-S044.
7.
De Vlam K, Lories RJ, Luyten FP: Mechanisms of pathologic new bone formation. Curr Rheumatol Rep. 2006, 8: 332-337.CrossRefPubMed
8.
Lories RJ, Luyten FP: Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev. 2005, 16: 287-298. 10.1016/j.cytogfr.2005.02.009.CrossRefPubMed
9.
Lories RJU, Derese I, Ceuppens JL, Luyten FP: Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum. 2003, 48: 2807-2818. 10.1002/art.11389.CrossRefPubMed
10.
Miyazono K, Maeda S, Imamura T: BMP receptor signaling: transcriptional targets, regulation of signals, and signaling crosstalk. Cytokine Growth Factor Rev. 2005, 16: 251-263. 10.1016/j.cytogfr.2005.01.009.CrossRefPubMed
11.
Urist MR: Bone: formation by autoinduction. Science. 1965, 150: 893-899. 10.1126/science.150.3698.893.CrossRefPubMed
12.
Kronenberg HM: Developmental regulation of the growth plate. Nature. 2003, 423: 332-336. 10.1038/nature01657.CrossRefPubMed
13.
Luyten FP, Lories RJ, De Bari C, De Valck D, Dell'Accio F: Bone morphogenetic proteins and the synovial joint. Bone Morphogenetic Proteins: fRegeneration of Bone and Beyond. Edited by: Vukicevic S, Sampath KT. 2004, Basel: Birckhäuser AG, 187-212.CrossRef
14.
Martinovic S, Borovecki F, Sampath KT, Vukicevic S: Biology of bone morphogenetic proteins. Bone Morphogenetic Proteins: Regeneration of Bone and Beyond. Edited by: Vukicevic S, Sampath KT. 2004, Basel: Birckhäuser AG, 45-72.CrossRef
15.
Balemans W, Van Hul W: Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol. 2002, 250: 231-250.CrossRefPubMed
16.
Hoffmann A, Preobrazhenska O, Wodarczyk C, Medler Y, Winkel A, Shahab S, Huylebroeck D, Gross G, Verschueren K: Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors. J Biol Chem. 2005, 280: 27271-27283. 10.1074/jbc.M503368200.CrossRefPubMed
17.
Lories RJU, Derese I, Luyten FP: Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest. 2005, 115: 1571-1579. 10.1172/JCI23738.PubMedCentralCrossRefPubMed
18.
Lories RJ, Daans M, Matthys P, Kasran A, Tylzanowski P, Ceuppens JL, Luyten FP: Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum. 2006, 54: 1736-1746. 10.1002/art.21897.CrossRefPubMed
19.
Lories RJ, Matthys P, Derese I, De Vlam K, Luyten FP: Ankylosing enthesitis, dactylitis and onychoperiostitis in a mouse model of psoriatic arthritis. Ann Rheum Dis. 2004, 63: 595-598. 10.1136/ard.2003.013599.PubMedCentralCrossRefPubMed
20.
Holmdahl R, Jansson L, Andersson M, Jonsson R: Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice. Clin Exp Immunol. 1992, 88: 467-472.PubMedCentralCrossRefPubMed
21.
Matthys P, Lories RJ, De Klerck B, Heremans H, Luyten FP, Billiau M: Dependence on interferon-gamma for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum. 2003, 48: 2983-2988. 10.1002/art.11273.CrossRefPubMed
22.
Glansbeek HL, van Beuningen HM, Vitters EL, Morris EA, van der Kraan PM, van den Berg WB: Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1alpha effects on proteoglycan synthesis and content. Arthritis Rheum. 1997, 40: 1020-1028. 10.1002/art.1780400605.CrossRefPubMed
23.
van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB: Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage. 1998, 6: 306-317. 10.1053/joca.1998.0129.CrossRefPubMed
24.
van Lent PL, Blom AB, van der KP, Holthuysen AE, Vitters E, van Rooijen N, Smeets RL, Nabbe KC, van den Berg WB: Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum. 2004, 50: 103-111. 10.1002/art.11422.CrossRefPubMed
25.
Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, van den Berg WB: Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage. 2004, 12: 627-635. 10.1016/j.joca.2004.03.003.CrossRefPubMed
26.
Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB: Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum. 2003, 48: 3442-3451. 10.1002/art.11328.CrossRefPubMed
27.
Blaney Davidson EN, Vitters EL, van der Kraan PM, van den Berg WB: Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis. 2006, 65: 1414-1421. 10.1136/ard.2005.045971.CrossRefPubMed
28.
Zoricic S, Maric I, Bobinac D, Vukicevic S: Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat. 2003, 202: 269-277.PubMedCentralCrossRefPubMed
29.
Nakase T, Miyaji T, Tomita T, Kaneko M, Kuriyama K, Myoui A, Sugamoto K, Ochi T, Yoshikawa H: Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthritis Cartilage. 2003, 11: 278-284. 10.1016/S1063-4584(03)00004-9.CrossRefPubMed
30.
McGonagle D, Gibbon W, Emery P: Classification of inflammatory arthritis by enthesitis. Lancet. 1998, 352: 1137-1140. 10.1016/S0140-6736(97)12004-9.CrossRefPubMed
31.
Francois RJ, Braun J, Khan MA: Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides. Curr Opin Rheumatol. 2001, 13: 255-264. 10.1097/00002281-200107000-00003.CrossRefPubMed
32.
Moskowitz RW: Bone remodeling in osteoarthritis: subchondral and osteophytic responses. Osteoarthritis Cartilage. 1999, 7: 323-324. 10.1053/joca.1998.0181.CrossRefPubMed
33.
Menkes CJ, Lane NE: Are osteophytes good or bad?. Osteoarthritis Cartilage. 2004, 12 (Suppl A): S53-S54. 10.1016/j.joca.2003.09.003.CrossRefPubMed
34.
Lories RJ, Derese I, De Bari C, Luyten FP: Evidence for uncoupling of inflammation and joint remodeling in a mouse model of Spondyloarthritis. Arthritis Rheum. 2007, 56: 489-497. 10.1002/art.22372.CrossRefPubMed
35.
Rountree RB, Schoor M, Chen H, Marks ME, Harley V, Mishina Y, Kingsley DM: BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol. 2004, 2: e355-10.1371/journal.pbio.0020355.PubMedCentralCrossRefPubMed
36.
van der Kraan PM, Vitters EL, van Beuningen HM, van de Loo FA, van den Berg WB: Role of nitric oxide in the inhibition of BMP-2-mediated stimulation of proteoglycan synthesis in articular cartilage. Osteoarthritis Cartilage. 2000, 8: 82-86. 10.1053/joca.1999.0275.CrossRefPubMed
37.
Luyten FP: Mesenchymal stem cells in arthritis. Rheumatoid Arthritis: Frontiers in Pathofysiology and Treatment. Edited by: Panayi GS, Firestein GS, Wollheim FA. 2005, Oxford: Oxford University Press, 551-559.
38.
Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ: Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum. 2000, 43: 2046-2055. 10.1002/1529-0131(200009)43:9<2046::AID-ANR16>3.0.CO;2-8.CrossRefPubMed
39.
Marinova-Mutafchieva L, Williams RO, Funa K, Maini RN, Zvaifler NJ: Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum. 2002, 46: 507-513. 10.1002/art.10126.CrossRefPubMed
40.
Sen M: Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford). 2005, 44: 708-713. 10.1093/rheumatology/keh553.CrossRef
41.
Bramlage CP, Haupl T, Kaps C, Ungethum U, Krenn V, Pruss A, Muller GA, Strutz F, Burmester GR: Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther. 2006, 8: R58-10.1186/ar1923.PubMedCentralCrossRefPubMed
42.
De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001, 44: 1928-1942. 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P.CrossRefPubMed
43.
Steenvoorden MM, Tolboom TC, van der PG, Lowik C, Visser CP, Degroot J, Gittenberger-Degroot AC, Deruiter MC, Wisse BJ, Huizinga TW, et al: Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther. 2006, 8: R165-10.1186/ar2073.PubMedCentralCrossRefPubMed
44.
Filer A, Pitzalis C, Buckley CD: Targeting the stromal microenvironment in chronic inflammation. Curr Opin Pharmacol. 2006, 6: 393-400. 10.1016/j.coph.2006.03.007.PubMedCentralCrossRefPubMed
45.
Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996, 149: 1607-1615.PubMedCentralPubMed
46.
Yamanishi Y, Boyle DL, Pinkoski MJ, Mahboubi A, Lin T, Han Z, Zvaifler NJ, Green DR, Firestein GS: Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol. 2002, 160: 123-130.PubMedCentralCrossRefPubMed
47.
Edwards JC: Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res. 2000, 2: 344-347. 10.1186/ar110.PubMedCentralCrossRefPubMed
48.
49.
Buckley CD, Filer A, Haworth O, Parsonage G, Salmon M: Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Ann Rheum Dis. 2004, 63 (Suppl 2): ii92-ii95. 10.1136/ard.2004.028332.PubMedCentralPubMed
Metadaten
Titel
Bone morphogenetic proteins in destructive and remodeling arthritis
verfasst von
Rik JU Lories
Frank P Luyten
Publikationsdatum
01.04.2007
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 2/2007
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2135

Weitere Artikel der Ausgabe 2/2007

Arthritis Research & Therapy 2/2007 Zur Ausgabe

Research article

Peroxisome proliferator-activated receptor γ1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1β in articular chondrocytes

Research article

Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes

Review

Developments in the synovial biology field 2006

Research article

Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus

Research article

Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis

Research article

Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise